FGFR3 and plasma cell myeloma: Interestingly, the relative frequency of different FGFR3 mutations is dependent on the tumour type, with multiple myeloma mostly showing changes in the tyrosine-kinase domain [44], and bladder and cervical tumours mainly exhibiting mutations of the extracellular region.